Hard to Treat Diseases Inc. (HTDS)

Overview

Hard to Treat Diseases Inc. is a pioneering entity in the biopharmaceutical industry that focuses on the manufacturing, supplying, and exporting a broad spectrum of biopharmaceuticals and vaccines, catering to a global clientele. With an operational base rooted in Shenzhen, China, the company has rapidly expanded its horizons since its inception in 2009. By leveraging advanced biotechnological processes and a deep understanding of medical needs across different regions, Hard to Treat Diseases Inc. has carved out a significant presence not just within China, but also on an international scale. The company's strategic marketing efforts are primarily targeted towards emerging markets in South Asia, South-east Asia, Central and South America, and the Middle East, aiming to address some of the most challenging healthcare needs in these regions.

Products and Services

Hard to Treat Diseases Inc. offers an extensive portfolio of biopharmaceuticals, chemicals, and vaccines designed to meet a wide range of healthcare needs. Below is a detailed overview of their offerings:

• Biologicals:
  • Reteplase (rPA): A recombinant plasminogen activator used in the treatment of acute myocardial infarction.
  • Mycobacterium vaccae: A vaccine employed for immunotherapy in the treatment of tuberculosis and other mycobacterial diseases.
  • Acutobin Urinary Kallidinogenase: Used for treating acute cerebral infarction and other conditions related to vascular dysfunction.
  • Ulinastatin: An enzyme inhibitor used in the treatment of pancreatitis, sepsis, and inflammatory disorders.
  • Cerebroprotein Hydrolysate for Injection: Aimed at improving cognitive functions for patients suffering from stroke, head injuries, and Alzheimer's disease.
• Chemicals:
  • Cobratide Injection: Used as an anti-inflammatory and analgesic.
  • Entecavir Capsule: An antiviral medication for treating hepatitis B.
  • HES (Hydroxyethyl starch): Utilized in volume replacement therapy.
  • Dasatinib Tablets: A tyrosine-kinase inhibitor used in the treatment of chronic myeloid leukemia.
  • Thymosin a1 for Injection: Enhances immune response, used in the treatment of hepatitis B and C, and as an adjunct for cancer therapy.
  • Imipenem and Cilastatin Sodium for Injection: A broad-spectrum antibiotic used to treat a variety of bacterial infections.
  • Meropenem for Injection: Another broad-spectrum antibiotic for treating complicated infections.
• Vaccines:
  • Rabies Vaccine: Prevents rabies after exposure or for those at high risk of infection.
  • ACYW135 Meningococcal Vaccine: Protects against meningitis caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
  • Influenza Vaccine: Provides immunity against the flu.
  • Hepatitis A Vaccine: Prevents Hepatitis A virus infections.
  • Varicella Vaccine: Offers protection against chickenpox.